Provided by Tiger Trade Technology Pte. Ltd.

Brainsway Ltd.

22.99
+0.30001.32%
Post-market: 22.990.00000.00%18:41 EST
Volume:29.25K
Turnover:679.79K
Market Cap:450.08M
PE:89.89
High:23.58
Open:23.01
Low:22.71
Close:22.69
52wk High:25.65
52wk Low:7.84
Shares:19.58M
Float Shares:12.09M
Volume Ratio:0.34
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2558
EPS(LYR):0.1107
ROE:10.95%
ROA:1.92%
PB:6.42
PE(LYR):207.62

Loading ...

Analysts Are Bullish on Top Healthcare Stocks: ImmunityBio (IBRX), Brainsway (BWAY)

TIPRANKS
·
Jan 26

Brainsway price target raised to $30 from $24 at H.C. Wainwright

TIPRANKS
·
Jan 26

Brainsway price target raised to $30 from $23 at Northland

TIPRANKS
·
Jan 22

Brainsway announces U.S. FDA granted PMA for Neurolief’s ProlivRx system

TIPRANKS
·
Jan 12

Brainsway Says Premera Blue Cross Blue Shield Expands Coverage to Include Depression Treatment

MT Newswires Live
·
Jan 07

Brainsway Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 08, 2025

Brainsway Ltd : H.c. Wainwright Raises Target Price to $24 From $18

THOMSON REUTERS
·
Dec 08, 2025

BrainsWay Begins Clinical Trial of Deep TMS 360 System in Alcohol Use Disorder

MT Newswires Live
·
Nov 17, 2025

Brainsway price target raised to $18 from $17 at H.C. Wainwright

TIPRANKS
·
Nov 13, 2025

BrainsWay Receives FDA Clearance for Adolescent Depression Treatment

MT Newswires Live
·
Nov 13, 2025

Brainsway’s Deep TMS device granted FDA clearance in Major Depressive Disorder

TIPRANKS
·
Nov 13, 2025

Brainsway Is Maintained at Outperform by Northland Capital Markets

Dow Jones
·
Nov 13, 2025

Brainsway Ltd : Northland Capital Raises Target Price to $23 From $19

THOMSON REUTERS
·
Nov 12, 2025

BrainsWay Q3 EPS $0.04 Misses $0.07 Estimate, Sales $13.512M Beat $13.041M Estimate

Benzinga
·
Nov 11, 2025

Press Release: BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights

Dow Jones
·
Nov 11, 2025

Brainsway Ltd expected to post earnings of 6 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

Northland Securities Sticks to Their Buy Rating for Brainsway (BWAY)

TIPRANKS
·
Sep 17, 2025

Brainsway Says US FDA Approves Accelerated Protocol for Major Depression Treatment System

MT Newswires Live
·
Sep 16, 2025

Brainsway receives FDA clearance for accelerated Deep TMS for MDD

TIPRANKS
·
Sep 16, 2025

Brainsway Price Target Maintained With a $17.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 25, 2025